Antithrombotic Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Global Antithrombotic Drug Market is segmented by Drug Class (Thrombolytic Drugs, Anti-platelet Drugs, and Anticoagulants), Route of Administration (Oral and Parenteral), Application (Pulmonary Embolism, Deep Vein Thrombosis, Atrial Fibrillation and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Antithrombotic Drugs Market Size

Antithrombotic Drugs Market Summary

Antithrombotic Drugs Market Analysis

The Antithrombotic Drugs Market is expected to register a CAGR of 7.5% during the forecast period.

The COVID-19 pandemic imposed a high burden on the healthcare industry, increasing its focus on providing better healthcare facilities, monitoring devices, services, and teleconsultation. For instance, according to the NCBI article published in June 2021, more than half (53%) of the countries surveyed partially or completely disrupted services for hypertension treatment, and 31% for cardiovascular emergencies. Thus, the reduction in cardiovascular care services during the initial stages of the pandemic due to the strict lockdown procedures imposed by various governments had a significant impact on the market's growth during the pandemic period. However, the relaxation of stringent regulations during the post-pandemic period is expected to restore market growth over the next five years.

Certain factors that are propelling the growth of the market are the increase in the prevalence of cardiac and hereditary diseases and the growing demand for novel oral anticoagulants, coupled with the ageing population.

The rising burden of cardiac and hereditary diseases is the major factor driving demand for the antithrombotic drug market. For instance, the British Heart Foundation (BHF) data published in January 2022 reported that in 2021, the most common heart conditions affected globally were coronary (ischemic) heart disease (global prevalence estimated at 200 million), peripheral arterial (vascular) disease (110 million), stroke (100 million), and atrial fibrillation (60 million). The report also mentioned that the prevalence of heart and circulatory diseases in North America was 46 million, in Europe it was 99 million, in Africa it was 58 million, in South America it was 32 million, and in Asia and Australia it was 310 million. Such an increase in cardiovascular disease across the world is expected to increase the demand for antithrombotic drugs, thereby propelling market growth.

In addition, the increasing incidence and prevalence of diabetes mellitus and obesity among the population are also contributing to the demand for antithrombotic drugs as these patients are more susceptible to atherosclerotic cardiovascular events. In such cases, antiplatelet drugs are the secondary prevention method that reduces the risk of atherosclerotic cardiovascular events and their adverse prognostic consequences. For instance, according to the 2022 statistics published by the International Diabetes Federation in the 10th edition of 2021, in Germany, 6,199.9 thousand people lived with diabetes in 2021. Thus, an increasing number of people living with diabetes are at high risk of developing cardiovascular diseases, which is expected to increase the demand for antithrombotic drugs, thereby propelling market growth.

However, the stringent regulatory policies, high cost, and side effects of antithrombotic drugs are likely to restrain market growth over the forecast period.

Antithrombotic Drugs Industry Overview

The antithrombotic drug market is highly competitive, with a large number of local or regional players. The companies are focusing on adopting various business strategies, such as drug development, product launches, and geographic expansions. Some of the key players operating in the market include Bristol-Myers Squibb Company, AstraZeneca plc, Eli Lilly and Company, C.H. Boehringer Sohn AG & Co. KG, and Aspen Holdings, among others.

Antithrombotic Drugs Market Leaders

  1. Bristol-Myers Squibb Company

  2. AstraZeneca plc

  3. Eli Lilly and Company

  4. Aspen Holdings

  5. Boehringer Ingelheim International GmbH

  6. *Disclaimer: Major Players sorted in no particular order
Antithrombotic Drugs Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Antithrombotic Drugs Market News

  • March 2022: CytoSorbents announced the enrollment of the first patient in the trial of the DrugSorb- ATR anti-thrombotic removal system to remove direct oral coagulants apixaban and rivaroxaban at the time of cardiothoracic surgery.
  • February 2022: the United States Food and Drug Administration granted Fast Track designation to Bayer's oral Factor Xia inhibitor Asundexian, under phase II trial, as an anticoagulant for the treatment of arterial and venous thrombosis.

Antithrombotic Drugs Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increase in Prevalence of Cardiac and Hereditary Diseases
    • 4.2.2 Growing Demand For Novel Oral Anticoagulants Coupled with the Ageing Population
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Policies
    • 4.3.2 High Cost and Side Effects of Antithrombotic Drugs
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value in USD million)

  • 5.1 By Drug Class
    • 5.1.1 Thrombolytic Drugs
    • 5.1.2 Anti-platelet Drugs
    • 5.1.3 Anticoagulants
  • 5.2 By Route of Administration
    • 5.2.1 Oral
    • 5.2.2 Parenteral
  • 5.3 By Application
    • 5.3.1 Pulmonary Embolism
    • 5.3.2 Deep Vein Thrombosis
    • 5.3.3 Atrial Fibrillation
    • 5.3.4 Other Applications
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Sanofi S.A.
    • 6.1.2 Bayer AG
    • 6.1.3 Eli Lilly and Company
    • 6.1.4 AstraZeneca plc
    • 6.1.5 Boehringer Ingelheim International GmbH
    • 6.1.6 Otsuka Pharmaceutical Co., Ltd.
    • 6.1.7 Novartis AG
    • 6.1.8 Aspen Holdings
    • 6.1.9 Bristol-Myers Squibb Company
    • 6.1.10 Hikma Pharmaceuticals
    • 6.1.11 Fresenius Kabi AG
    • 6.1.12 Daiichi Sankyo Company
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Antithrombotic Drugs Industry Segmentation

As per the scope of the report, antithrombotic drugs are used to reduce the formation of blood clots (thrombi). These drugs include those that inhibit platelet aggregation, form fibrin strands, and dissolve existing clots. The antithrombotic drugs market is segmented by drug class (thrombolytic drugs, antiplatelet drugs, and anticoagulants), route of administration (oral and parenteral), application (pulmonary embolism, deep vein thrombosis, atrial fibrillation, and others), and geography (North America, Europe, Asia-Pacific, the Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Drug Class Thrombolytic Drugs
Anti-platelet Drugs
Anticoagulants
By Route of Administration Oral
Parenteral
By Application Pulmonary Embolism
Deep Vein Thrombosis
Atrial Fibrillation
Other Applications
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Antithrombotic Drugs Market Research FAQs

What is the current Antithrombotic Drugs Market size?

The Antithrombotic Drugs Market is projected to register a CAGR of 7.5% during the forecast period (2025-2030)

Who are the key players in Antithrombotic Drugs Market?

Bristol-Myers Squibb Company, AstraZeneca plc, Eli Lilly and Company, Aspen Holdings and Boehringer Ingelheim International GmbH are the major companies operating in the Antithrombotic Drugs Market.

Which is the fastest growing region in Antithrombotic Drugs Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Antithrombotic Drugs Market?

In 2025, the North America accounts for the largest market share in Antithrombotic Drugs Market.

What years does this Antithrombotic Drugs Market cover?

The report covers the Antithrombotic Drugs Market historical market size for years: 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Antithrombotic Drugs Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

MEA Metal Cans Industry Report

Statistics for the 2025 Antithrombotic Drugs market share, size and revenue growth rate, created by Mordor Intelligenceā„¢ Industry Reports. Antithrombotic Drugs analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Antithrombotic Drugs Market Report Snapshots

Compare market size and growth of Antithrombotic Drugs Market with other markets in Healthcare Industry

Antithrombotic Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)